Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2024.08.09

Sai Life Sciences elevates Compound Management process with in-house software application, CORAL

Compound management is a vital function in pharmaceutical research. A streamlined environment can bring significant value to the process in the form of productivity and efficiency.

Recognizing the importance of this function, we have made our Compound Management suite for Discovery services smarter with the introduction of an in-house software application, Compound Organization and Registration Automated Logistics System, or CORAL.

At its core, CORAL seamlessly integrates with existing applications such as Mosaic Sample Bank (a centralized software solution for inventory management) and Tecan Liquid Handler (an automated tool for liquid handling tasks), streamlining the compound lifecycle management process.

By automating these critical processes, it minimizes the need for frequent manual intervention and enhances overall operational efficiency.

“With CORAL, we’re transforming how compound management is done—making it smarter, faster, and more reliable. By seamlessly connecting with tools like Mosaic and Tecan, CORAL reduces manual work and boosts efficiency, helping us focus more on advancing discoveries," said a Team Lead – Project Management at Sai Life Sciences.

This integrated solution represents a step forward in our commitment to operational excellence in compound management. By leveraging CORAL alongside Tecan and Mosaic, Sai Life Sciences continues to drive innovation, enhance reliability, and elevate the quality of research outcomes.

Share article

More News

2024.10.28

Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) for its R&D (Unit II, Hyderabad), and Manufacturing (Unit IV, Bidar) sites in India. The General Good Manufacturing Practices (GMP) audit was conducted at the […]
Read more

2024.10.07

Sai Life Sciences releases Sustainability Report 2024

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its Sustainability Report for 2023-2024. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, this fifth edition of the Sustainability Report is based on the theme, ‘Synergising Sustainability, Performance and Growth.’ The full report can be read here. Making […]
Read more

2024.07.29

Sai Life Sciences inducts 96 trainees across campuses in India

“I just got my first pair of safety shoes and I’m thrilled! Exploring the facility for the first time is such a joy!” – Spurthi R, Trainee, Medicinal Chemistry, Shamirpet. Ushering in a season of new beginnings, we welcomed 96 trainees across our campuses in India. These young individuals have been selected from eight colleges […]
Read more

2024.02.08

Sai Life Sciences releases its Sustainability Report 2023

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), released its Sustainability Report 2022-2023. Developed in accordance with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, the fourth edition of the Sustainability report is based on the theme ‘Steadfast on Sustainability,’ and it articulates the company’s commitment to sustainability […]
Read more

2024.02.01

Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations

To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), has expanded its DMPK capabilities. The expansion comprises the addition of 25,000 sq. ft. of state-of-the-art labs equipped with cutting-edge instrumentation enabling high-end automation. Complementing the expansion has been […]
Read more